Law360, New York (March 09, 2012, 7:47 PM ET) -- The Food and Drug Administration on Thursday moved to streamline its tracking of potential postmarket drug problems, releasing draft guidelines for a new way to prioritize different problems within the agency's sprawling computer tracking system.
The FDA said it hoped the changes would help it respond more quickly to the most serious problems, especially those with the potential to be fatal.
The FDA's drug division uses the system, known as the Document Archiving, Reporting, and Regulatory Tracking System, or DARRTS, to keep tabs on both premarket...
FDA Moves To Improve Tracking Of Drug Safety Issues
To view the full article, take a free trial now.
